Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 774-789
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.774
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.774
ICF component | Domain | Category | Outcome measures | Count primary1 | Organ group |
Body Function | Global mental functions | b134 | Sleep quality and quantity | 1 | Kidney |
b152 | Mood status | 0 | Lung | ||
Functions of the cardiovascular system (heart functions) | b410 | Cardiac output | 0 | Heart, kidney | |
b410 | Carotid intima-media thickness | 0 | Kidney | ||
b410 | Echocardiographic parameters | 2 | Heart | ||
b410 | Endothelial function | 2 | Heart | ||
b410 | Left ventricular systolic function | 0 | Heart | ||
b410 | RR interval | 0 | Heart | ||
b410 | Stroke volume | 0 | Heart, kidney | ||
b410 | Systemic vascular endurance | 0 | Kidney | ||
Functions of the cardiovascular system (heart rate) | b4100 | Heart rate | 1 | Heart, kidney, lung | |
b4100 | Heart rate recovery | 1 | Heart | ||
b4100 | Heart rate reserve | 1 | Heart | ||
b4100 | Heart rate variability | 1 | Kidney | ||
Functions of the cardiovascular system | b410-429 | Baroceptor control of blood pressure | 1 | Heart | |
b410-429 | Baroceptor control of heart rate | 1 | Heart | ||
b410-429 | Baroflex effectiveness index | 0 | Kidney | ||
b410-429 | Baroflex sensitivity | 1 | Kidney | ||
b410-429 | Chronotropic response index | 1 | Heart | ||
b410-429 | Total CVD risk | 1 | Kidney | ||
b410-429 | Cardiac allograft vasculopathy | 1 | Heart | ||
Functions of the cardiovascular system (blood vessel | b415 | Arterial stiffness | 3 | Heart, kidney | |
functions) | b415 | Brachial artery diameter | 0 | Heart | |
Functions of the cardiovascular system (blood | b420 | Arterial pressure | 0 | Kidney | |
pressure functions) | b420 | Blood pressure | 4 | Heart, kidney, lung | |
b420 | Neck pressure | 0 | Heart | ||
Functions of the cardiovascular system (oxygen-carrying functions of the blood) | b4301 | Arteriovenous oxygen difference | 0 | Kidney | |
Functions of the hematological and immunological | b430-439 | Biochemical parameters | 0 | Heart | |
systems | b430-439 | Blood calcium level | 0 | Kidney | |
b430-439 | Blood creatinine | 0 | Heart, kidney | ||
b430-439 | Blood electrolytes | 0 | Kidney | ||
b430-439 | Blood glucose | 1 | Heart, kidney | ||
b430-439 | Blood lipids | 2 | Heart, kidney, lung | ||
b430-439 | Blood phosphorus | 0 | Kidney | ||
b430-439 | Blood protein levels | 1 | Heart, kidney | ||
b430-439 | Blood urea nitrogen levels | 0 | Kidney | ||
b430-439 | C-reactive protein | 1 | Heart | ||
b430-439 | Cholesterol | 3 | Heart, kidney | ||
b430-439 | Folate concentrations | 0 | Kidney | ||
b430-439 | Hematocrit | 0 | Kidney | ||
b430-439 | Hemoglobin | 0 | Heart, kidney | ||
b430-439 | High sensitive C-reactive protein | 0 | Heart | ||
b430-439 | Interleukin levels | 2 | Heart, kidney | ||
b430-439 | Plasma norepinephrine | 0 | Heart | ||
b430-439 | Soluble cell adhesion molecules | 1 | Heart | ||
b430-439 | Total-homocysteine | 0 | Kidney | ||
b430-439 | Tumour necrosis factor-alpha | 2 | Heart | ||
B430-439 | Tumor necrosis factor receptor | 0 | Kidney | ||
b435 | Cytomegalovirus IgG status | 0 | Heart | ||
b435 | White blood cell levels | 0 | Heart | ||
b435 | Acute rejection episodes | 0 | Heart, lung | ||
Functions of the respiratory system (respiration functions) | b440 | Forced expiratory volume | 0 | Lung | |
functions) | b440 | Forced vital capacity | 1 | Heart | |
b440 | Maximum expiratory/inspiratory pressure | 0 | Heart | ||
b440 | Peak expiratory flow | 0 | Kidney | ||
b440 | Peak respiratory exchange ratio | 1 | Heart, kidney, liver, lung | ||
b440 | Respiratory compensation point | 0 | Heart | ||
b440 | Ventilatory reserve and capacity | 0 | Lung | ||
Functions of the respiratory system (respiration rate) | b4400 | CO2 production | 0 | Heart | |
b4400 | Oxygen uptake at anaerobic threshold | 0 | Lung | ||
b4400 | Peak ventilation | 2 | Heart, kidney | ||
b4400 | Peak VO2 | 13 | Heart, kidney, liver, lung | ||
b4400 | Ventilatory equivalent for carbon dioxide and oxygen | 1 | Heart | ||
Functions of the respiratory system (respiratory muscle functions) | b445 | Respiratory muscle force/strength | 1 | Heart, lung | |
Functions of the cardiovascular system (general physical endurance) | b4550 | Rating of perceived exertion | 0 | Heart, kidney, liver | |
Functions related to the digestive, metabolism and the endocrine system | b530 | Body mass index | 4 | Heart, kidney, liver | |
endocrine system | b530 | Body weight/mass | 3 | Heart, kidney, liver, lung | |
b530 | Fat mass/body fat | 3 | Heart, kidney, liver | ||
b530 | Fat-free mass | 1 | Heart | ||
b530 | Hip girth | 0 | Kidney | ||
b530 | Hip-waist ratio | 0 | Heart | ||
b530 | Lean tissue mass | 2 | Heart, kidney, liver | ||
b530 | Percent body fat | 2 | Heart, kidney, liver | ||
b530 | Visceral fat scale | 0 | Heart | ||
b530 | Waist girth | 0 | Kidney | ||
General metabolic functions, unspecified | b5400 | Basal metabolic rate | 0 | Heart | |
b5400 | Metabolic age | 0 | Heart | ||
General metabolic functions, other, specified | B5408 | Maximal metabolic units | 1 | Kidney | |
Functions related to metabolism and the endocrine system | b540-559 | Enzyme levels | 0 | Kidney | |
system | b540-559 | Fetuin A | 0 | Kidney | |
b540-559 | Oxidative stress-induced lipid peroxidation | 0 | Heart | ||
b540-559 | Serum insulin | 1 | Heart | ||
b540-559 | Serum metabolic and/or hematologic profile | 1 | Heart | ||
b540-559 | Vitamin B12 | 0 | Kidney | ||
b540-559 | Glycemic control parameters | 0 | Heart, kidney | ||
b540-559 | Muscle metabolic enzyme activity | 1 | Heart | ||
b545 | Body water | 0 | Heart | ||
b545 | Homeostasis model assessment | 0 | Heart | ||
Functions of the genitourinary and reproductive functions (urinary functions) | b610-639 | Glomerular filtration rate | 1 | Kidney | |
Neuromusculoskeletal and movement-related functions (muscle power functions) | b730 | Peak workload/power output | 1 | Heart, kidney, lung | |
b730 | Muscle strength | 7 | Heart, kidney, liver, lung | ||
b730-b749 | Muscle vasodilation | 1 | Heart | ||
b740 | Muscle endurance | 1 | Heart | ||
Body structure | Structures related to movement - additional musculoskeletal structures related to movement (bones) | s7700 | Bone mass | 0 | Heart |
s7700 | Bone mineral content | 1 | Heart, kidney, liver | ||
s7700 | Bone mineral density | 3 | Heart, kidney, liver, lung | ||
s7700 | Total bone calcium | 0 | Heart | ||
s7702 | Muscle composition (fibre types) | 1 | Heart | ||
Activities and participation | Mobility - walking and moving | d410 | STS-60 | 0 | Kidney |
participation | Mobility - walking and moving (walking) | d450 | Daily steps | 0 | Lung |
d450 | Daily walking time | 1 | Lung | ||
d450 | 6 Minute Walk Distance | 3 | Heart, liver, lung | ||
d450 | Anaerobic threshold | 1 | Heart, lung | ||
Mobility - walking and moving | d450-469 | Daily physical activity | 0 | Heart | |
d450-469 | Movement intensity | 0 | Lung | ||
d450-469 | Self-reported activity level | 0 | Kidney | ||
d450-469 | Time spent in moderate intense activities | 0 | Lung | ||
d450-469 | Duke Treadmill Score | 0 | Heart | ||
d450-469 | Exercise duration | 1 | Heart, kidney | ||
Managing diet and fitness | d5701 | Caloric intake | 0 | Heart | |
d5701 | Nutritional intake | 1 | Liver | ||
Major life areas (work and employment) | d840-859 | Employment status | 1 | Kidney | |
Environmental factors | Products or substances for personal consumption, other specified | e1108 | Smoking status | 0 | Kidney |
Drugs | e1101 | Immunosuppression use | 0 | Kidney | |
Questionnaires | DASI | 0 | Kidney | ||
Quality of Life Profile for Chronic Diseases Questionnaire | 1 | Lung | |||
SF-36 | 8 | Heart, kidney, liver, lung | |||
St. George’s Respiratory Questionnaire | 1 | Lung | |||
State-Trait Anxiety Inventory | 1 | Heart | |||
Beck Depression Inventory | 1 | Heart | |||
Hospital Anxiety and Depression Scale | 2 | Heart | |||
Visual Analog Scale (change in HRQoL) | 0 | Heart | |||
WHOQOL-BREF | 2 | Heart, kidney | |||
Not covered by ICF | Chronic Liver Disease Questionnaire | 1 | Liver | ||
Incidence of morbidity | 0 | Kidney, lung | |||
Adherence to training and follow-up | 2 | Kidney |
- Citation: Janaudis-Ferreira T, Mathur S, Konidis S, Tansey CM, Beaurepaire C. Outcomes in randomized controlled trials of exercise interventions in solid organ transplant. World J Transplant 2016; 6(4): 774-789
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/774.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.774